Dermapharm
DMP.F
$33.88
Share price
2.26%
Change (1 day)
-30.62%
Change (1 year)
Dermapharm (DMP.F) - Cash on Hand
Cash on Hand as of September 2023 : $0.15 B
According to Dermapharm's latest financial reports the company has $0.15 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Dermapharm - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.17 B | -11.32% |
| 2021-12-31 | $0.19 B | 31.42% |
| 2020-12-31 | $0.14 B | 14.07% |
| 2019-12-31 | $0.12 B | -46.88% |
| 2018-12-31 | $0.24 B | 2948.36% |
| 2017-12-31 | $8.02 M | 93.25% |
| 2016-12-31 | $4.15 M | 36.12% |
| 2015-12-31 | $3.05 M | -78.45% |
| 2014-12-31 | $14.16 M | 119.84% |
| 2013-12-31 | $6.44 M |